Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inhibrx Biosciences (INBX) Current Assets: 2023-2024

Historic Current Assets for Inhibrx Biosciences (INBX) over the last 2 years, with Dec 2024 value amounting to $160.4 million.

  • Inhibrx Biosciences' Current Assets fell 22.19% to $161.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $161.4 million, marking a year-over-year decrease of 22.19%. This contributed to the annual value of $160.4 million for FY2024, which is 45.69% down from last year.
  • Latest data reveals that Inhibrx Biosciences reported Current Assets of $160.4 million as of FY2024, which was down 45.69% from $295.4 million recorded in FY2023.
  • Inhibrx Biosciences' Current Assets' 5-year high stood at $295.4 million during FY2023, with a 5-year trough of $160.4 million in FY2024.
  • Moreover, its 2-year median value for Current Assets was $227.9 million (2023), whereas its average is $227.9 million.
  • Data for Inhibrx Biosciences' Current Assets shows a maximum YoY tumbled of 45.69% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Inhibrx Biosciences' Current Assets stood at $295.4 million in 2023, then crashed by 45.69% to $160.4 million in 2024.